We are live on ! Find out more
AC

Aisling Capital Portfolio holdings

AUM $45.3M
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
-7.54%
1 Year Est. Return
-15.24%
3 Year Est. Return
+386.13%
5 Year Est. Return
+981.36%
10 Year Est. Return
AUM
$60.3M
AUM Growth
-$6.21M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 31.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMT
1
DELISTED
Aimmune Therapeutics
AIMT
$41.4M 68.67%
1,990,000
ADMA icon
2
ADMA Biologics
ADMA
$1.98B
$14M 23.14%
3,608,171
ASXC
3
DELISTED
Asensus Surgical, Inc.
ASXC
$3.23M 5.35%
183,796
CDTX
4
DELISTED
Cidara Therapeutics
CDTX
$1.72M 2.84%
51,057

Similar funds

Aisling Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Aisling Capital held 4 positions worth $60.3M, down 9.3% from $66.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Aisling Capital opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier.

  • Aisling Capital's ten largest holdings make up 100% of its $60.3M portfolio in Q2 2019.
  • Aisling Capital opened 0 new positions and closed 0 in Q2 2019.
  • Aisling Capital's portfolio value fell 9.3% quarter-over-quarter to $60.3M.

Based on Aisling Capital's 13F filing for Q2 2019, filed 8 Aug 2019.